We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Synthetic Bone Material Shows Promise in Spinal Fusion

By HospiMedica staff writers
Posted on 20 May 2002
Preliminary results from three ongoing studies in Europe and the United States show that patients who received a synthetic bone void filler material called Vitoss in a spinal fusion procedure have progressed successfully to a solid fusion at the three-to-six month followup. More...


The study involved 95 patients who received Vitoss as an autograft extender or as an allograft extender. Unlike donor bone materials from cadavers, Vitoss poses no risk of biocontamination, infection, or rejection. Vitoss is a highly porous scaffold composed of nanometer-sized calcium phosphate particles with 90% interconnecting porosity that are designed to replicate the characteristics of human cancellous bone and allow for resorption, cell seeding, and ingrowth of host bone. Use of Vitoss can avoid the need to harvest bone from other areas in the body or use cadaver bone materials, says Orthovita, Inc. (Malvern, PA, USA), which developed the synthetic bone material.

"While autograft remains the gold standard for lumbar spinal fusions, these studies indicate that Vitoss can offer significant advantages as an extender to autograft or allograft, and in some cases can even be used alone successfully,” said Raymond Linovitz, MD, a spine surgeon in San Diego (CA, USA) and a lead investigator on one of the studies.




Related Links:
Orthovita

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.